SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-08-090337
Filing Date
2008-04-25
Accepted
2008-04-25 10:01:15
Documents
6
Period of Report
2008-06-10
Effectiveness Date
2008-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE & PROXY STATEMENT ddef14a.htm DEF 14A 543630
2 GRAPHIC g51422g15f87.jpg GRAPHIC 9078
3 GRAPHIC g51422g80n92.jpg GRAPHIC 6975
4 GRAPHIC g51422g97s96.jpg GRAPHIC 15789
5 GRAPHIC g51422pc1.jpg GRAPHIC 185520
6 GRAPHIC g51422pc2.jpg GRAPHIC 102826
  Complete submission text file 0001193125-08-090337.txt   986950
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31577 | Film No.: 08776137
SIC: 2834 Pharmaceutical Preparations